The SARS-CoV-2–neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine

Detalles Bibliográficos
Autores principales: Pedersen, Rune M., Bang, Line L., Tornby, Ditte S., Kierkegaard, Helene, Nilsson, Anna C., Johansen, Isik S., Bistrup, Claus, Jensen, Thøger G., Justesen, Ulrik S., Andersen, Thomas E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450277/
https://www.ncbi.nlm.nih.gov/pubmed/34547366
http://dx.doi.org/10.1016/j.kint.2021.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450277/
https://www.ncbi.nlm.nih.gov/pubmed/34547366
http://dx.doi.org/10.1016/j.kint.2021.09.006

Ejemplares similares